Tyra Biosciences, Inc. (TYRA) Social Stream



Tyra Biosciences, Inc. (TYRA): $15.11

1.43 (+10.45%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add TYRA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#118 of 381

in industry

TYRA BIOSCIENCES INC (TYRA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering TYRA BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 3 $31 $22 $26.5 $14.53 82.38%
2021-11-12 3 $31 $31 $31 $14.53 113.35%
2022-03-04 3 $31 $26 $28.5 $14.53 96.15%
2022-03-08 3 $27 $26 $26.5 $14.53 82.38%
2022-08-08 4 $27 $12 $21.666 $14.53 49.11%
2022-08-10 4 $26 $12 $21.333 $14.53 46.82%
2022-11-04 4 $26 $12 $21 $14.53 44.53%
2023-01-26 4 $25 $12 $20 $14.53 37.65%
2023-03-01 5 $25 $12 $19.25 $14.53 32.48%
2023-03-02 5 $25 $15 $22 $14.53 51.41%
2023-03-07 4 $25 $17 $22.5 $14.53 54.85%
2023-03-23 5 $25 $17 $22.5 $14.53 54.85%
2023-05-07 5 $25 $17 $23 $14.53 58.29%

The Trend in the Analyst Price Target


TYRA's average price target has moved down $3.5 over the prior 18 months.

TYRA reports an average of 106.93% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-08 4 27 12 21.666 11.03 96.43%
2022-11-04 4 26 12 20.333 6.50 212.82%
2023-02-03 5 25 12 19.250 13.18 46.05%
2023-02-08 5 25 12 19.250 13.07 47.28%
2023-03-24 5 25 17 23.000 15.95 44.2%

TYRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


TYRA's average broker recommendation rating improved by 0 over the prior 26 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, TYRA BIOSCIENCES INC's number of analysts covering the stock is higher than 238.89% of them.
  • To contextualize these metrics, consider that out of all US stocks, TYRA BIOSCIENCES INC's variance in analysts' estimates is lower than -645.67% of them.
  • TYRA has a greater average analyst price target than 433.17% of all US stocks.
  • TYRA has a greater upside potential (average analyst target price relative to current price) than 484.43% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, THRX, PYXS, and XLO are the three stocks most similar to TYRA BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

What is the outlook for TYRA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7807 seconds.